877 filings
Page 10 of 44
8-K
hv3t5zxwg zmvas0bk
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
ulg7v7d75o60qmiz0ia3
28 Oct 19
Entry into a Material Definitive Agreement
4:40pm
8-K
mw0atcw9
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
0sck1yj2khdf 5sk
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
DEF 14C
ojlk0wqt 29x7deyxx
18 Jul 19
Information statement
4:49pm
UPLOAD
oluohujm3sc
18 Jul 19
Letter from SEC
12:00am
PRER14C
zi6w1xg29d3zn
17 Jul 19
Preliminary revised information
5:29pm
CORRESP
h0gb2r 83b
17 Jul 19
Correspondence with SEC
12:00am
UPLOAD
tts11h m85me24dext2
3 Jul 19
Letter from SEC
12:00am
PRE 14C
8r1ub
24 Jun 19
Preliminary information
4:25pm
8-K
3tna0txy
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
NT 10-Q/A
nks o14mh07f6sye
16 May 19
Notice of late quarterly filing (amended)
9:46pm
EFFECT
ga30bospkbzv
16 May 19
Notice of effectiveness
12:15am
NT 10-Q
lihvf
15 May 19
Notice of late quarterly filing
4:34pm
CORRESP
am4g94okg346umcqyzs
15 May 19
Correspondence with SEC
12:00am
UPLOAD
wpmc0u bm
7 May 19
Letter from SEC
12:00am
8-K
6ki9em5n8nl8
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm